HEPATORENAL SYNDROME
Clinical trials for HEPATORENAL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new HEPATORENAL SYNDROME trials appear
Sign up with your email to follow new studies for HEPATORENAL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device hopes to restore kidney function in liver patients
Disease control TerminatedThis study tests a device called the Selective Cytopheretic Device (SCD) in 10 ICU patients with acute kidney injury and hepatorenal syndrome, a serious complication of liver disease. The device filters certain white blood cells over 7 days to see if it can improve kidney functio…
Matched conditions: HEPATORENAL SYNDROME
Phase: NA • Sponsor: Lenar Yessayan • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for deadly Liver-Kidney complication
Disease control OngoingThis study is testing whether a drug called ambrisentan can help people with hepatorenal syndrome, a serious kidney complication that occurs in advanced liver cirrhosis and often leads to death. Researchers are comparing ambrisentan against the standard treatment, terlipressin, i…
Matched conditions: HEPATORENAL SYNDROME
Phase: PHASE2 • Sponsor: Noorik Biopharmaceuticals AG • Aim: Disease control
Last updated Apr 16, 2026 13:02 UTC